ArticlePloS one2022
Tolerance to soil acidity of soybean (Glycine max L.) genotypes under field conditions Southwestern Ethiopia.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Variability of Ethiopian Chickpea (Plants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soil acidity with associated low nutrient availability is one of the major constraints to soybean production in southwestern Ethiopia. Integrated use of lime and acid-tolerant crops is believed to reduce soil acidity and improve crop production. The experiment was conducted in the field condition of Mettu, southwestern Ethiopia during the 2017/18 main cropping season. The experiment comprised fifteen soybean genotypes and two soil amendment (lime and unlimed) treatments arranged in a split-plot design with three replications. For each treatment, four rows were planted per plot; data related to growth, root, nodule, and yield of the crop were collected at a necessary stage for each. Liming and genotype interaction had significantly (P = 0.01) affected all parameters considered except for hundred seed weight and root volume and were affected only by the main effects of genotypes and liming. A significant reduction for most parameters was found on lime-untreated soil than treated soil. Though some genotypes showed higher performance for root, growth parameters, and yield components under unlimed soils; however, gave higher yield and yield components, when grown on lime-untreated with an average yield reduction of 13.7%, due to soil acidity. The maximum grain yield of (1943.93 kg ha-1) was obtained under lime treated acid soil from PI567046A genotype; while the lowest (510.49 kg ha-1) were recorded from SCS-1genotype under the lime untreated acid soil. Genotype BRS268 showed higher yield (1319.83 kg ha-1) under lime untreated acid soil than lime treated acid soil (1143.47 kg ha-1) and showed less reduction percentage for a number of the nodules, root weight, and number of seeds per plant; while PI567046A showed high reduction percentage for yield, biomass, number of pod and seed per plant. A high difference was observed among the soybean genotypes for soil acidity tolerance, which might be further exploited by breeders for the genetic improvement of soybean. Genotype BRS268 had performed better than other tested genotypes under increased soil acidity. selection would be effective to improve soybean genotypes performance on acid soils and identify low Phosphorus tolerant genotype that helps smallholder farmers optimize soybean productivity on acid soils in the study area. HAWASSA-04 variety is the most tolerant among the tested materials. However, further study is required by considering additional genotypes to reach a conclusive recommendation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.